Biesterfield buys fellow API distributor Schütz

By Staff Reporter

- Last updated on GMT

Image: iStock/nightman1965
Image: iStock/nightman1965

Related tags Pharmacology Active ingredient

Biesterfeld says the acquisition of fellow Germany-based distributor Schütz strengthens the firm’s focus on specialty chemicals.

German distribution company Biesterfeld has bought Schütz & Co., a Hamburg-based business focused on the distribution of customised active pharmaceutical ingredients (API) and excipients, for an undisclosed fee.

According to a Biesterfeld spokesperson, the addition of Schütz “strengthens [the firm’s] core competencies and [its] focus on specialty chemicals and customer-specific solutions​.”

“The service and product range of Schütz & Co. is an ideal addition to our portfolio for the pharmaceutical and cosmetics industries,”​ this publication was told.

The deal, which went through on August 1, will see Biesterfeld take on numerous long-standing partnerships with manufacturers for the supply of ingredients to pharma and cosmetic companies across more than 50 companies.

Related news

Show more

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Manufacturing Drugs with Highly Potent APIs

Manufacturing Drugs with Highly Potent APIs

Content provided by Altasciences | 28-Sep-2023 | White Paper

In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs),...

Follow us

Products

View more

Webinars